Uluer, A. Z., MacGregor, G., Azevedo, P., Indihar, V., Keating, C., Mall, M. A., McKone, E. F., Ramsey, B. W., Rowe, S. M., Rubenstein, R. C., Taylor-Cousar, J. L., Tullis, E., Yonker, L. M., Chu, C., Lam, A. P., Nair, N., Sosnay, P. R., Tian, S., Van Goor, F., … Wilson, J. (2023). Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. The Lancet Respiratory Medicine, 11(6), 550–562. https://doi.org/10.1016/s2213-2600(22)00504-5
Subjects:
Cystic Fibrosis
(MeSH)
Therapeutic Advances in Cystic Fibrosis Research
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1016/s2213-2600(22)00504-5
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: